UC Berkeley’s startup accelerator takes university research discoveries and helps translate them into marketable products.
O’Reilly Bio chronicles the stories of the biological revolution from academic labs, startup companies, community lab spaces, and all who are inspired to make research and tools collaborative, accessible, low-cost, and efficient.
DNA holds the key to storing vast amounts of digital data
The basic technology behind gene editing and a conversation between Jennifer Doudna and Siddhartha Mukherjee.
As the cost of developing new drugs rises, researchers are investigating new ways to use existing medicines
Advances in 3D-printing technology have the potential to lower the cost and increase the availability of organ transplants.
Learn how biohacking is unlocking human potential.
Learn how the Defense Advanced Research Projects Agency (DARPA) has spurred significant advances in the promising field of synthetic biology.
New technology is allowing doctors to diagnose and treat heart disease faster and more efficiently.
Several new apps are making it easier for doctors and patients to conduct clinical trials.
CGMs are unique in the way consumers have taken it upon themselves to create modifications to medical devices.
The FDA is entering a new era of regulation as whole genome sequencing becomes more accessible to consumers.
Startups and individuals on the cusp of biological breakthroughs.
GV, Google's venture capital arm, is investing in several promising biotechnology startups.
Bioprinting, a technology that emerged from open source communities, has the potential to improve medical science.
Electronic waste is an economic and environmental problem, but citizen scientists can take action by using harvested sensors from discarded electronics.
Exciting new genetic testing technology has improved the speed and accuracy of cancer diagnosis.
There’s beauty in biology—and the biotech industry is ready to make a move
Shreya Thiagarajan describes the invaluable experience she gained while working in a local community lab.
The accelerator is helping scientists turn their moonshot visions into viable businesses, fast.
New technology is allowing researchers to use digitization to help detect cancer.
A look at the cutting-edge technology featured at the most recent IndieBio Demo Day.
Miroculus democratizes early cancer detection with an open research database and a digital microfluidic platform.
Everyday citizens are becoming empowered to contribute to modern medical science.
NemaMetrix’s ScreenChip collects live-animal, high-throughput C. elegans elecropharyngeograms (EPGs), which are an indication of overall organism health for drug development.